mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |